| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |